Monster Beverage's risk/reward into today's investor meeting is negative, Wells Fargo analyst Bonnie Herzog told investors last night in a research note. She said her outlook for the company "continues to deteriorate" due to soft category trends, Java production issues, the "poor" rollout of Mutant and retailers' "modest" outlook for Monster in 2017. She expects "weak" Q4 results from the company and continues to have "more questions than answers." Herzog lowered her price target range for the shares to $44-$46 from $49-$51 and keeps a Market Perform rating on the name. Monster Beverage is down 83c to $43.16 in morning trading.